Results 31 to 40 of about 1,025,996 (357)

COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation

open access: yesClinical and applied thrombosis/hemostasis, 2020
The novel coronavirus infection (COVID-19) is caused by the new coronavirus SARS-CoV-2 and is characterized by an exaggerated inflammatory response that can lead to severe manifestations such as adult respiratory syndrome, sepsis, coagulopathy, and death
Wolfgang A. Miesbach, M. Makris
semanticscholar   +1 more source

Cancer patients’ experiences of living with venous thromboembolism: A systematic review and qualitative thematic synthesis [PDF]

open access: yes, 2018
Background: Cancer-Associated thrombosis is common. Recommended treatment is daily injected low-molecular-weight heparin for 6months. Most studies focus on prophylaxis and treatment; few have explored patients’ experience.
Benelhaj, Naima B.   +5 more
core   +1 more source

Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series

open access: yesAnnals of Internal Medicine, 2020
Background: Coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly become pandemic, with substantial mortality.
S. Lax   +8 more
semanticscholar   +1 more source

Vascular complications after liver transplantation: A 5-year experience [PDF]

open access: yes, 1986
During the past 5 years, 104 angiographic studies were performed in 87 patients (45 children and 42 adults) with 92 transplanted livers for evaluation of possible vascular complications. Seventy percent of the studies were abnormal.
Bron, KM   +4 more
core   +1 more source

Hepatic artery thrombosis after liver transplantation: Radiologic evaluation [PDF]

open access: yes, 1986
Hepatic artery thrombosis after liver transplantation is a devastating event requiring emergency retransplantation in most patients. Early clinical signs are often nonspecific.
Bowen, A   +6 more
core   +1 more source

Thrombosis risk associated with COVID-19 infection. A scoping review

open access: yesThrombosis Research, 2020
Background Infection by the 2019 novel coronavirus (COVID-19) has been reportedly associated with a high risk of thrombotic complications. So far information is scarce and rapidly emerging.
F. Al-Ani   +2 more
semanticscholar   +1 more source

Evaluation of platelet function in thrombocytopenia

open access: yesPlatelets, 2018
Whole blood aggregometry is a functional assay for determination of platelet function. Until now, whole blood aggregometry has not been considered feasible at low platelet counts.
Mette Tiedemann Skipper   +4 more
doaj   +1 more source

Potency Adjusted Blended Heparin of Bovine, Ovine, and Porcine Heparin Exhibit Comparable Biologic Effects to Referenced Single-Sourced Porcine Heparin

open access: yesClinical and Applied Thrombosis/Hemostasis, 2023
Introduction: Bovine and ovine mucosa represent alternate anticoagulants to porcine mucosa for production of unfractionated heparin (UFH). Standardized heparins from various sources can be blended and potency adjusted, blended heparins exhibit comparable
Guy Olson BS   +8 more
doaj   +1 more source

Risk marker associations with venous thrombotic events: a cross-sectional analysis. [PDF]

open access: yes, 2014
ObjectiveTo examine the interrelations among, and risk marker associations for, superficial and deep venous events-superficial venous thrombosis (SVT), deep venous thrombosis (DVT) and pulmonary embolism (PE).DesignCross-sectional analysis.SettingSan ...
Chan, Virginia T   +4 more
core   +1 more source

Functional Genomics for the Identification of Modulators of Platelet-Dependent Thrombus Formation

open access: yesTH Open, 2018
Despite the absence of the genome in platelets, transcription profiling provides important insights into platelet function and can help clarify abnormalities in platelet disorders.
Elien Vermeersch   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy